LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 80.31 | 27.76 | 5530 | 6976 | 0.7927 | 0.9426 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 80.31 | 27.76 | 806 | 6976 | 0.1155 | 0.5257 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 80.31 | 27.76 | 8499 | 6976 | 1.2183 | 1.0501 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 82.01 | 27.76 | 9 | 7000 | 0.0013 | -0.1317 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 82.01 | 27.76 | 5406 | 7000 | 0.7723 | 0.9363 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 82.01 | 27.76 | 820 | 7000 | 0.1171 | 0.5286 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 82.01 | 27.76 | 8734 | 7000 | 1.2477 | 1.0562 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 83.72 | 27.76 | 7 | 7055 | 0.0010 | -0.1584 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 83.72 | 27.76 | 5445 | 7055 | 0.7717 | 0.9362 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 83.72 | 27.76 | 879 | 7055 | 0.1246 | 0.5411 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 83.72 | 27.76 | 8909 | 7055 | 1.2627 | 1.0592 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 85.42 | 27.76 | 15 | 7025 | 0.0021 | -0.0742 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 85.42 | 27.76 | 5087 | 7025 | 0.7241 | 0.9207 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 85.42 | 27.76 | 945 | 7025 | 0.1345 | 0.5556 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 85.42 | 27.76 | 9059 | 7025 | 1.2894 | 1.0647 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 87.13 | 27.76 | 20 | 6987 | 0.0029 | -0.0403 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 87.13 | 27.76 | 4620 | 6987 | 0.6612 | 0.8989 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 87.13 | 27.76 | 904 | 6987 | 0.1294 | 0.5476 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 87.13 | 27.76 | 9248 | 6987 | 1.3234 | 1.0715 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 88.84 | 27.76 | 17 | 6965 | 0.0024 | -0.0597 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 88.84 | 27.76 | 4345 | 6965 | 0.6238 | 0.8850 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 88.84 | 27.76 | 925 | 6965 | 0.1328 | 0.5525 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 88.84 | 27.76 | 9413 | 6965 | 1.3515 | 1.0770 | MN20160318_Q01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 90.55 | 27.76 | 10 | 6928 | 0.0014 | -0.1203 | MN20160318_Q01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 90.55 | 27.76 | 4213 | 6928 | 0.6081 | 0.8789 | MN20160318_Q01 | C22 |